ABSTRACT -Non-clinical animal studies to assess the safety of compounds under development have
INTRODUCTION
Non-clinical safety studies are necessary to assess the safety and toxicity profiles of drug compounds under development. Usually, these studies, including investigations into genotoxicity, chronic toxicity, reproductive toxicity, immunotoxicity, and carcinogenicity, among others, are performed using experimental animals. Non-clini--ity of non-clinical safety data for the application of drug -lations cover organization, facilities, training, documenta--facility and the actual studies performed at the facili- Table 2 .
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addition, starting and completion dates of the study are -must ensure that the final report reflects the raw data ------ious study types, were still allowed to operate, and this is documents including protocols and raw data, and final cases it is easier for pharmaceutical companies to understand the contents. This issue is important from the proand carry out audits themselves to evaluate the appropriateness of a study. 
